FDA updates COVID-19 testing guidelines to allow self-swab tests

FDA updates COVID-19 testing guidelines to allow self-swab tests

4 years ago
Anonymous $9CO2RSACsf

https://techcrunch.com/2020/03/23/fda-updates-covid-19-testing-guidelines-to-allow-self-swab-tests/

The U.S. Food and Drug Administration (FDA) has updated its guidelines for COVID-19 testing procedures, in a bid to both make the process easier and less uncomfortable for patients, and to help limit the impact of testing on the supply of personal protective equipment (PPE) used by healthcare workers, including protective masks, face shields, gloves and gowns.

The change means that people undertaking a test will be able to conduct their own swab, which will involve swabbing shallowly in their nose. The existing process required a healthcare professional to take the swab, and to collect a sample from further up in the nasal cavity. This change does not mean there’s any difference in the FDA’s guidance regarding at-home sample collection – that is still specifically disallowed by the agency’s rules, something the FDA clarified over the weekend in order to put an end to at-home test collection kits being distributed by diagnostic startups.

FDA updates COVID-19 testing guidelines to allow self-swab tests

Mar 23, 2020, 11:33pm UTC
https://techcrunch.com/2020/03/23/fda-updates-covid-19-testing-guidelines-to-allow-self-swab-tests/ > The U.S. Food and Drug Administration (FDA) has updated its guidelines for COVID-19 testing procedures, in a bid to both make the process easier and less uncomfortable for patients, and to help limit the impact of testing on the supply of personal protective equipment (PPE) used by healthcare workers, including protective masks, face shields, gloves and gowns. > The change means that people undertaking a test will be able to conduct their own swab, which will involve swabbing shallowly in their nose. The existing process required a healthcare professional to take the swab, and to collect a sample from further up in the nasal cavity. This change does not mean there’s any difference in the FDA’s guidance regarding at-home sample collection – that is still specifically disallowed by the agency’s rules, something the FDA clarified over the weekend in order to put an end to at-home test collection kits being distributed by diagnostic startups.